FUS has been shown to promote a T-cell-mediated anti-tumor response, characterized by decreased tumor growth and proliferation [137]; increased infiltration of activated, tumor-specific effector CD4+ and CD8+ T-cells; and increased infiltration of inflammatory macrophages [138,139]. The gene discussed is CD4; the disease is neoplasm.